Linscomb Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $900K | Sell |
6,458
-737
| -10% | -$103K | 0.04% | 205 |
|
|
2025
Q4 | $883K | Sell |
7,195
-182
| -2% | -$22.1K | 0.04% | 183 |
|
|
2025
Q3 | $819K | Sell |
7,377
-2,706
| -27% | -$308K | 0.04% | 194 |
|
|
2025
Q2 | $1.12M | Sell |
10,083
-126
| -1% | -$13.4K | 0.05% | 166 |
|
|
2025
Q1 | $1.14M | Buy |
10,209
+3,503
| +52% | +$361K | 0.06% | 160 |
|
|
2024
Q4 | $619K | Sell |
6,706
-1,464
| -18% | -$132K | 0.03% | 211 |
|
|
2024
Q3 | $685K | Sell |
8,170
-1,076
| -12% | -$82.1K | 0.03% | 203 |
|
|
2024
Q2 | $634K | Sell |
9,246
-164
| -2% | -$10.9K | 0.03% | 201 |
|
|
2024
Q1 | $689K | Sell |
9,410
-1,017
| -10% | -$78.2K | 0.04% | 195 |
|
|
2023
Q4 | $845K | Sell |
10,427
-265
| -2% | -$20.6K | 0.05% | 170 |
|
|
2023
Q3 | $801K | Sell |
10,692
-666
| -6% | -$51.2K | 0.05% | 170 |
|
|
2023
Q2 | $875K | Sell |
11,358
-1,814
| -14% | -$145K | 0.05% | 165 |
|
|
2023
Q1 | $1.09M | Sell |
13,172
-4,940
| -27% | -$409K | 0.06% | 160 |
|
|
2022
Q4 | $1.55M | Sell |
18,112
-490
| -3% | -$38.8K | 0.08% | 150 |
|
|
2022
Q3 | $1.15M | Buy |
18,602
+190
| +1% | +$12K | 0.07% | 148 |
|
|
2022
Q2 | $1.14M | Sell |
18,412
-358
| -2% | -$22.2K | 0.07% | 149 |
|
|
2022
Q1 | $1.12M | Sell |
18,770
-9,329
| -33% | -$596K | 0.05% | 174 |
|
|
2021
Q4 | $2.04M | Buy |
28,099
+2,283
| +9% | +$157K | 0.1% | 130 |
|
|
2021
Q3 | $1.8M | Buy |
25,816
+1,265
| +5% | +$88.9K | 0.09% | 133 |
|
|
2021
Q2 | $1.69M | Buy |
24,551
+2,928
| +14% | +$196K | 0.09% | 132 |
|
|
2021
Q1 | $1.4M | Buy |
21,623
+1,153
| +6% | +$74.3K | 0.08% | 144 |
|
|
2020
Q4 | $1.19M | Buy |
20,470
+2,509
| +14% | +$151K | 0.07% | 147 |
|
|
2020
Q3 | $1.14M | Buy |
17,961
+1,371
| +8% | +$95.1K | 0.08% | 138 |
|
|
2020
Q2 | $1.28M | Buy |
16,590
+6,594
| +66% | +$505K | 0.09% | 127 |
|
|
2020
Q1 | $747K | Buy |
9,996
+2,344
| +31% | +$162K | 0.07% | 180 |
|
|
2019
Q4 | $497K | Buy |
7,652
+1,581
| +26% | +$103K | 0.03% | 321 |
|
|
2019
Q3 | $385K | Buy |
6,071
+245
| +4% | +$16K | 0.03% | 213 |
|
|
2019
Q2 | $394K | Buy |
5,826
+84
| +1% | +$5.53K | 0.03% | 205 |
|
|
2019
Q1 | $373K | Buy |
5,742
+145
| +3% | +$9.64K | 0.03% | 210 |
|
|
2018
Q4 | $350K | Sell |
5,597
-1,457
| -21% | -$102K | 0.03% | 196 |
|
|
2018
Q3 | $545K | Buy |
7,054
+350
| +5% | +$26.4K | 0.04% | 174 |
|
|
2018
Q2 | $475K | Buy |
6,704
+297
| +5% | +$21K | 0.04% | 182 |
|
|
2018
Q1 | $483K | Buy |
6,407
+7
| +0.1% | +$556 | 0.04% | 172 |
|
|
2017
Q4 | $459K | Buy |
6,400
+354
| +6% | +$26.9K | 0.04% | 187 |
|
|
2017
Q3 | $490K | Buy |
6,046
+240
| +4% | +$18.4K | 0.04% | 174 |
|
|
2017
Q2 | $411K | Buy |
5,806
+531
| +10% | +$35.3K | 0.04% | 186 |
|
|
2017
Q1 | $358K | Buy |
5,275
+154
| +3% | +$10.8K | 0.03% | 187 |
|
|
2016
Q4 | $367K | Sell |
5,121
-38
| -0.7% | -$2.82K | 0.03% | 193 |
|
|
2016
Q3 | $408K | Buy |
5,159
+327
| +7% | +$26.6K | 0.04% | 180 |
|
|
2016
Q2 | $403K | Sell |
4,832
-19
| -0.4% | -$1.69K | 0.04% | 177 |
|
|
2016
Q1 | $446K | Buy |
4,851
+1,081
| +29% | +$97.5K | 0.05% | 168 |
|
|
2015
Q4 | $382K | Buy |
3,770
+223
| +6% | +$23.2K | 0.04% | 185 |
|
|
2015
Q3 | $348K | Buy |
3,547
+421
| +13% | +$46.8K | 0.04% | 193 |
|
|
2015
Q2 | $366K | Buy |
3,126
+307
| +11% | +$33.5K | 0.04% | 197 |
|
|
2015
Q1 | $277K | Sell |
2,819
-119
| -4% | -$12.1K | 0.03% | 229 |
|
|
2014
Q4 | $277K | Buy |
2,938
+208
| +8% | +$21.5K | 0.03% | 228 |
|
|
2014
Q3 | $291K | Buy |
+2,730
| New | +$267K | 0.03% | 226 |
|
Other funds holding GILD
VCM
VPM
Linscomb Wealth's GILD Position: Q1 2026 in Review
Linscomb Wealth reduced its Gilead Sciences (GILD) stake by 10% in Q1 2026, selling an estimated $103K and leaving 6,458 shares worth $900K. The position accounts for 0.04% of the portfolio, ranked #205.
Linscomb Wealth first reported a position in GILD in Q3 2014 and has held it in 47 quarters since. The position peaked at $2.04M in Q4 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Linscomb Wealth held 6,458 shares of Gilead Sciences worth $900K as of Q1 2026.
- Linscomb Wealth sold 737 Gilead Sciences shares in Q1 2026, an estimated $103K.
- Gilead Sciences made up 0.04% of Linscomb Wealth's portfolio in Q1 2026, its #205 holding.
- Linscomb Wealth first reported a position in Gilead Sciences in Q3 2014 and has held it in 47 quarters since.
- Linscomb Wealth's Gilead Sciences position peaked at $2.04M in Q4 2021.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Linscomb Wealth's 13F filing for Q1 2026, filed 11 May 2026.